The high prevalence and increasing incidence of obesity and associated cardiovascular risk emphasises the need to focus on obesity reduction in this high-risk population.

Metabolic syndrome (MetS) is the coexistence of obesity-related cardiovascular risk factors including hypertension, diabetes and dyslipidaemia. MetS is a precursor for atherosclerosis, including premature coronary artery disease, and cardiovascular mortality.

Close X
Other videos you might like

Recent Videos


EASD 22: SURMOUNT-MMO: Tirzepatide in Obese Type II Diabetes Patients

Steven E Nissen,

Watch time: 07m 48s

Video Series

Dysphagia and the Management of Patients in Need of Lipid-Lowering

Yassir Javaid, , , et al

Watch time: 1h 6m (4 videos)


SPLENDOR: Metabolic Surgery and Risk of MACE in NASH

Ali Aminian,


RESPONSE-2: Long Term Outcomes of Lifestyle Programme in CAD Patients

Harald Thune Jorstad,